Post Authorisation Safety Study With Raxone in LHON Patients

NCT02771379 · clinicaltrials.gov ↗

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Leber's Hereditary Optic Neuropathy (LHON)

Interventions

DRUG: Idebenone

Sponsor

Santhera Pharmaceuticals